Circulating Angiogenic T Cells Are Increased in Lupus Nephritis Patients

Circulating Angiogenic T Cells Are Increased in Lupus Nephritis Patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.12659/MSM.908406
P932PMC publication ID6087034
P698PubMed publication ID30072685

P2093author name stringPeng Zhao
Qing Han
Ping Zhu
Kui Zhang
Jinlin Miao
Minghua Lv
P2860cites workIsolation of putative progenitor endothelial cells for angiogenesisQ28302884
Local guidance of emerging vessel sprouts requires soluble Flt-1Q28590559
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean DietQ29030043
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosusQ29614922
Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cellsQ30438261
Cardiovascular risk factors and the long-term outcome of lupus nephritisQ31846096
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patientsQ33357081
Lupus nephritis.Q33601256
Premature coronary-artery atherosclerosis in systemic lupus erythematosusQ33974685
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosusQ34098573
Analysis of the role of chemokines in angiogenesis.Q35048828
Circulating Angiogenic T Cells and Their Subpopulations in Patients with Systemic Lupus ErythematosusQ36737988
Classification of lupus nephritisQ37448638
Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosisQ40494777
Mortality in lupus nephritisQ41668485
Vascular endothelial growth factor-A specifies formation of native collaterals and regulates collateral growth in ischemiaQ42734729
Circulating activated endothelial cells in systemic lupus erythematosus: further evidence for diffuse vasculopathyQ43607198
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.Q44441787
Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosusQ45738754
Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosusQ46462550
Circulating endothelial cells and their progenitors in systemic lupus erythematosus and early rheumatoid arthritis patients.Q47426474
Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies.Q53560989
Interleukin-17A induction of angiogenesis, cell migration, and cytoskeletal rearrangementQ59042033
Atherosclerosis and lupusQ80102951
Frequency of established cardiovascular disease and its risk factors in Chinese patients with systemic lupus erythematosusQ83115423
Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patientsQ84787597
Senescent profile of angiogenic T cells from systemic lupus erythematosus patientsQ85692780
Angiogenic T cells are decreased in rheumatoid arthritis patientsQ87050415
P407language of work or nameEnglishQ1860
P921main subjectlupus nephritisQ1621830
P304page(s)5384-5390
P577publication date2018-08-03
P1433published inMedical Science MonitorQ15756323
P1476titleCirculating Angiogenic T Cells Are Increased in Lupus Nephritis Patients
P478volume24

Reverse relations

Q90290759Angiogenic T cells are decreased in people with type 2 diabetes mellitus and recruited by the dipeptidyl peptidase-4 inhibitor Linagliptin: A subanalysis from a randomized, placebo-controlled trial (RELEASE study)cites workP2860

Search more.